{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:01:58Z","timestamp":1789185718906,"version":"build-2803163510"},"reference-count":67,"publisher":"Rockefeller University Press","issue":"7","content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1997,4,7]]},"abstract":"<jats:p>A new surface protein, named NspA, which is distinct from the previously described Neisseria meningitidis outer membrane proteins was identified. An NspA-specific mAb, named Me-1, reacted with 99% of the meningococcal strains tested indicating that the epitope recognized by this particular mAb is widely distributed and highly conserved. Western immunoblotting experiments indicated that mAb Me-1 is directed against a protein band with an approximate molecular mass of 22,000, but also recognized a minor protein band with an approximate molecular mass of 18,000. This mAb exhibited bactericidal activity against four meningococcal strains, two isolates of serogroup B, and one isolate from each serogroup A and C, and passively protected mice against an experimental infection. To further characterize the NspA protein and to evaluate the protective potential of recombinant NspA protein, the nspA gene was identified and cloned into a low copy expression vector. Nucleotide sequencing of the meningococcal insert revealed an ORF of 525 nucleotides coding for a polypeptide of 174 amino acid residues, with a predicted molecular weight of 18,404 and a isoelectric point of 9.93. Three injections of either 10 or 20 \u03bcg of the affinity-purified recombinant NspA protein efficiently protected 80% of the mice against a meningococcal deadly challenge comparatively to the 20% observed in the control groups. The fact that the NspA protein can elicit the production of bactericidal and protective antibodies emphasize its potential as a vaccine candidate.<\/jats:p>","DOI":"10.1084\/jem.185.7.1173","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T16:49:30Z","timestamp":1027702170000},"page":"1173-1184","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":117,"title":["Highly Conserved <i>Neisseria meningitidis<\/i> Surface Protein Confers Protection against Experimental Infection"],"prefix":"10.1084","volume":"185","author":[{"given":"Denis","family":"Martin","sequence":"first","affiliation":[{"name":"From Unit\u00e9 de Recherche en Vaccinologie, Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Qu\u00e9bec, Ste-Foy, Qu\u00e9bec, Canada, G1V 4G2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cadieux","sequence":"additional","affiliation":[{"name":"From Unit\u00e9 de Recherche en Vaccinologie, Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Qu\u00e9bec, Ste-Foy, Qu\u00e9bec, Canada, G1V 4G2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"Hamel","sequence":"additional","affiliation":[{"name":"From Unit\u00e9 de Recherche en Vaccinologie, Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Qu\u00e9bec, Ste-Foy, Qu\u00e9bec, Canada, G1V 4G2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard R.","family":"Brodeur","sequence":"additional","affiliation":[{"name":"From Unit\u00e9 de Recherche en Vaccinologie, Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Qu\u00e9bec, Ste-Foy, Qu\u00e9bec, Canada, G1V 4G2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[1997,4,7]]},"reference":[{"key":"2023072915192337400_B1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/clinids\/5.1.71","article-title":"Meningococcal disease: still with us","volume":"5","author":"Peltola","year":"1983","journal-title":"Rev Infect Dis"},{"key":"2023072915192337400_B2"},{"key":"2023072915192337400_B3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/004947557600600303","article-title":"Meningococcal meningitis in the northern savanna of Africa","volume":"6","author":"Whittle","year":"1976","journal-title":"Trop Doct"},{"key":"2023072915192337400_B4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/clinids\/7.4.504","article-title":"Serotype antigens of Neisseria meningitidisand a proposal scheme for designation of serotypes","volume":"7","author":"Frasch","year":"1988","journal-title":"Rev Infect Dis"},{"key":"2023072915192337400_B5"},{"key":"2023072915192337400_B6"},{"key":"2023072915192337400_B7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM197002192820803","article-title":"Prevention of meningococcal disease by group C polysaccharide vaccine","volume":"282","author":"Artenstein","year":"1970","journal-title":"N Engl J Med"},{"key":"2023072915192337400_B8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","article-title":"Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age","volume":"297","author":"Peltola","year":"1977","journal-title":"N Engl J Med"},{"key":"2023072915192337400_B9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0140-6736(85)90224-7","article-title":"Age specific difference in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine","volume":"2","author":"Reingold","year":"1985","journal-title":"Lancet"},{"key":"2023072915192337400_B10","first-page":"13","article-title":"Development of a meningococcal vaccine","volume":"4","author":"Poolman","year":"1995","journal-title":"Infect Agents Dis"},{"key":"2023072915192337400_B11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1542\/peds.60.5.673","article-title":"Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines","volume":"60","author":"Lepow","year":"1977","journal-title":"Pediatrics"},{"key":"2023072915192337400_B12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","article-title":"Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C","volume":"10","author":"Costantino","year":"1992","journal-title":"Vaccine"},{"key":"2023072915192337400_B13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4049\/jimmunol.127.3.1011","article-title":"Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates","volume":"127","author":"Jennings","year":"1981","journal-title":"J Immunol"},{"key":"2023072915192337400_B14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1128\/iai.40.1.39-45.1983","article-title":"Preparation and immunochemical characterization of meningococcal serogroup C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines","volume":"40","author":"Beuvery","year":"1983","journal-title":"Infect Immun"},{"key":"2023072915192337400_B15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0264-410X(83)90010-5","article-title":"Physiochemical and immunochemical characterization of meningococcal serogroup A polysaccharide-tetanus toxoid conjugates prepared by two methods","volume":"1","author":"Beuvery","year":"1983","journal-title":"Vaccine"},{"key":"2023072915192337400_B16","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/iai.62.8.3391-3395.1994","article-title":"Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults","volume":"62","author":"Anderson","year":"1994","journal-title":"Infect Immun"},{"key":"2023072915192337400_B17"},{"key":"2023072915192337400_B18","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.4049\/jimmunol.129.5.2172","article-title":"Measurement of antibodies to meningococcal serogroup B polysaccharide: Low avidity binding and equilibrium binding constants","volume":"129","author":"Mandrell","year":"1982","journal-title":"J Immunol"},{"key":"2023072915192337400_B19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/iai.40.1.257-264.1983","article-title":"Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide","volume":"40","author":"Zollinger","year":"1983","journal-title":"Infect Immun"},{"key":"2023072915192337400_B20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"2023072915192337400_B21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"2023072915192337400_B22","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.129.6.1367","article-title":"Human immunity to the meningococcus. IV. Immunogenicity of serogroup A and serogroup C polysaccharides in human volunteers","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"key":"2023072915192337400_B23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/infdis\/127.2.149","article-title":"Classification of Neisseria meningitidisserogroup b into distinct serotypes. III. Application of a new bactericidal inhibition technique to distribution of serotypes among cases and carriers","volume":"127","author":"Frasch","year":"1973","journal-title":"J Infect Dis"},{"key":"2023072915192337400_B24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1099\/00222615-12-1-107","article-title":"Development of antibodies to meningococcal protein and lipopolysaccharide antigens in healthy carriers","volume":"12","author":"Jones","year":"1979","journal-title":"J Med Microbiol"},{"key":"2023072915192337400_B25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0882-4010(87)90059-3","article-title":"Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidisB:15:P1.16 in infant rat infection model: new prospects for vaccine development","volume":"3","author":"Saukkonen","year":"1987","journal-title":"Microb Pathog"},{"key":"2023072915192337400_B26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0264-410X(89)90194-1","article-title":"Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat model and in vitro bactericidal assay","volume":"7","author":"Saukkonen","year":"1989","journal-title":"Vaccine"},{"key":"2023072915192337400_B27","first-page":"101","article-title":"Outer membrane proteins of Neisseria meningitidis: structure and importance in meningococcal disease","volume":"9","author":"Frasch","year":"1986","journal-title":"Clin Invest Med"},{"key":"2023072915192337400_B28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/iai.50.2.510-516.1985","article-title":"Protection against infection with Neisseria meningitidisgroup B serotype 2b by passive immunization with serotype-specific monoclonal antibody","volume":"50","author":"Brodeur","year":"1985","journal-title":"Infect Immun"},{"key":"2023072915192337400_B29","first-page":"147","article-title":"Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey","volume":"14","author":"H\u00f8iby","year":"1991","journal-title":"NIPH (Natl Inst Public Health) Ann (OSLO)"},{"key":"2023072915192337400_B30","first-page":"211","article-title":"Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile","volume":"14","author":"Zollinger","year":"1991","journal-title":"NIPH (Natl Inst Public Health) Ann (OSLO)"},{"key":"2023072915192337400_B31","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1128\/iai.59.9.2963-2971.1991","article-title":"Topology of outer membrane porins in pathogenic Neisseriaspp","volume":"59","author":"van der Ley","year":"1991","journal-title":"Infect Immun"},{"key":"2023072915192337400_B32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0882-4010(91)90029-A","article-title":"Cloning and expression in Escherichia coli of Opc, the gene for an unusual class 5 outer membrane protein from Neisseria meningitidis","volume":"11","author":"Olyhoek","year":"1991","journal-title":"Microbiol Pathog"},{"key":"2023072915192337400_B33","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/infdis\/167.5.1065","article-title":"The 5c protein of Neisseria meningitidisis highly immunogenic in humans and induces bactericidal antibodies","volume":"167","author":"Rosenqvist","year":"1993","journal-title":"J Infect Dis"},{"key":"2023072915192337400_B34","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1128\/iai.61.10.4217-4224.1993","article-title":"Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis","volume":"61","author":"van der Ley","year":"1993","journal-title":"Infect Immun"},{"key":"2023072915192337400_B35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0264-410X(95)98264-B","article-title":"Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine","volume":"13","author":"van der Ley","year":"1995","journal-title":"Vaccine"},{"key":"2023072915192337400_B36","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1128\/iai.60.8.3156-3161.1992","article-title":"Construction of multivalent class 1 OMP expressing meningococcal vaccine strain","volume":"60","author":"van der Ley","year":"1992","journal-title":"Infect Immun"},{"key":"2023072915192337400_B37","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/0264-410X(93)90045-Y","article-title":"Transferrin-binding proteins isolated from Neisseria meningitidiselicit protective and bactericidal antibodies in laboratory animals","volume":"11","author":"Danve","year":"1993","journal-title":"Vaccine"},{"key":"2023072915192337400_B38","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1128\/iai.58.9.3036-3041.1990","article-title":"Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidisare bactericidal and strains-specific","volume":"58","author":"Pettersson","year":"1990","journal-title":"Infect Immun"},{"key":"2023072915192337400_B39","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1128\/iai.58.9.2875-2881.1990","article-title":"Expression of Neisseria meningitidisiron-regulated outer membrane proteins including a 70-Kilodalton transferrin receptor, and their potential for use as vaccines","volume":"58","author":"Bhatnagar","year":"1990","journal-title":"Infect Immun"},{"key":"2023072915192337400_B40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0264-410X(95)00136-O","article-title":"The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains","volume":"14","author":"Ala'Aldeen","year":"1996","journal-title":"Vaccine"},{"key":"2023072915192337400_B41","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1128\/iai.43.3.994-999.1984","article-title":"Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenic Neisseriaspecies","volume":"43","author":"Cannon","year":"1984","journal-title":"Infect Immun"},{"key":"2023072915192337400_B42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1139\/m90-021","article-title":"Antibodies to meningococcal H.8 (Lip) antigen fail to show bactericidal activity","volume":"36","author":"Bhattacharjee","year":"1990","journal-title":"Can J Microbiol"},{"key":"2023072915192337400_B43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0882-4010(91)90041-8","article-title":"Blocking of bactericidal killing of Neisseria meningitidisby antibodies directed against class 4 outer membrane proteins","volume":"11","author":"Munkley","year":"1991","journal-title":"Microbiol Pathol"},{"key":"2023072915192337400_B44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-1119(85)90120-9","article-title":"Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors","volume":"33","author":"Yanisch-Perron","year":"1985","journal-title":"Gene (Amst)"},{"key":"2023072915192337400_B45"},{"key":"2023072915192337400_B46"},{"key":"2023072915192337400_B47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-1119(91)90366-J","article-title":"Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli","volume":"100","author":"Wang","year":"1991","journal-title":"Gene (Amst)"},{"key":"2023072915192337400_B48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"2023072915192337400_B49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1099\/00222615-23-2-163","article-title":"A monoclonal antibody directed against a serotype-specific, outer-membrane protein of Haemophilus influenzaetype b","volume":"23","author":"Hamel","year":"1987","journal-title":"J Med Microbiol"},{"key":"2023072915192337400_B50","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/01971528908053248","article-title":"Detection of Neisseria gonorrhoeaeby dot enzyme immunoassay using monoclonal antibodies","volume":"10","author":"Lussier","year":"1989","journal-title":"J Immunoassay"},{"key":"2023072915192337400_B51","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature (Lond)"},{"key":"2023072915192337400_B52","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/eji.1830180417","article-title":"Heterohybridomas secreting human monoclonal antibodies against Haemophilus influenzaetype b","volume":"18","author":"Martin","year":"1988","journal-title":"Eur J Immunol"},{"key":"2023072915192337400_B53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0003-2697(82)90673-X","article-title":"A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels","volume":"119","author":"Tsai","year":"1982","journal-title":"Annal Biochem"},{"key":"2023072915192337400_B54","doi-asserted-by":"crossref","first-page":"10035","DOI":"10.1016\/S0021-9258(18)61070-1","article-title":"Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes","volume":"262","author":"Matsudaira","year":"1987","journal-title":"J Biol Chem"},{"key":"2023072915192337400_B55","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1128\/iai.60.7.2718-2725.1992","article-title":"Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis","volume":"60","author":"Martin","year":"1992","journal-title":"Infect Immun"},{"key":"2023072915192337400_B56"},{"key":"2023072915192337400_B57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.mi.36.100182.002251","article-title":"Mechanism of incorporation of cell envelope proteins in Escherichia coli","volume":"36","author":"Michaelis","year":"1982","journal-title":"Ann Rev Microbiol"},{"key":"2023072915192337400_B58","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2958.1993.tb00922.x","article-title":"Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells","volume":"10","author":"Virji","year":"1993","journal-title":"Mol Microbiol"},{"key":"2023072915192337400_B59","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1365-2958.1991.tb00789.x","article-title":"Characterization of the opa (class 5) gene family of Neisseria meningitidis.","volume":"5","author":"Aho","year":"1991","journal-title":"Mol Microbiol"},{"key":"2023072915192337400_B60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2958.1994.tb01006.x","article-title":"Microevolution within a clonal population of pathogenic bacteria: recombination, gene duplication and horizontal genetic exchange in the opa gene family of Neisseria meningitidis","volume":"12","author":"Hobbs","year":"1994","journal-title":"Mol Microbiol"},{"key":"2023072915192337400_B61","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/infdis\/155.6.1266","article-title":"Killing of Neisseria meningitidisby human neutrophils: implications for normal and complement deficient individuals","volume":"155","author":"Ross","year":"1987","journal-title":"J Infect Dis"},{"key":"2023072915192337400_B62"},{"key":"2023072915192337400_B63","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1128\/iai.59.4.1457-1464.1991","article-title":"Mapping of B-cell epitopes on the outer membrane P2 porin protein of Haemophilus influenzaeby using recombinant proteins and synthetic peptides","volume":"59","author":"Martin","year":"1991","journal-title":"Infect Immun"},{"key":"2023072915192337400_B64","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2958.1993.tb01141.x","article-title":"Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology","volume":"7","author":"McGuinness","year":"1993","journal-title":"Mol Microbiol"},{"key":"2023072915192337400_B65","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/infdis\/166.6.1322","article-title":"Human monoclonal antibodies against an epitope on the class 5c outer membrane protein common to many pathogenic strains of Neisseria meningitidis","volume":"166","author":"Fernandez de Cossio","year":"1992","journal-title":"J Infect Dis"},{"key":"2023072915192337400_B66","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/cdli.1.6.729-736.1994","article-title":"Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodies","volume":"1","author":"Verheul","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"2023072915192337400_B67","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0264-410X(95)00101-6","article-title":"The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis","volume":"13","author":"Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4","year":"1995","journal-title":"Vaccine"}],"container-title":["The Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/185\/7\/1173\/1896693\/5463.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/185\/7\/1173\/1896693\/5463.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T15:19:58Z","timestamp":1690643998000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/185\/7\/1173\/25591\/Highly-Conserved-Neisseria-meningitidis-Surface"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4,7]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1997,4,7]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.185.7.1173","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4,7]]}}}